Bernardo Montesanti Machado de Almeida

Dr. Bernardo Montesanti Machado de Almeida

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2022 in Viruses
Verified
Journal Article
Open access
PDF file
DADouglas Adamoski
Douglas Adamoski
VBValter Antonio de Baura
Valter Antonio de Baura
ARAna Carolina Rodrigues
Ana Carolina Rodrigues
CRCarla Adriane Royer
Carla Adriane Royer
MAMateus Aoki
Mateus Aoki
Jaqueline Carvalho de OliveiraJaqueline Carvalho de Oliveira
Jaqueline Carvalho de Oliveira
Screening efforts and genomic surveillance are essential tools to evaluate the course of the COVID-19 pandemic and assist the public healthcare system in dealing with an increasing number of infections. For the analysis of COVID-19 cases scenarios in Curitiba, Paraná, Brazil, we performed a diagnosis of positive cases, coupled with genotyping, for symptomatic and asymptomatic members of the Federal University of Paraná. We achieved over 1000 samples using RT-qPCR for diagnosis. The posterior genotyping allowed us to observe differences in the spread of strains in Curitiba, Brazil. The Delta variant was not associated with an infection wave, whereas the rapid Omicron variant spread became dominant in less than one month. We also evaluated the general vaccination coverage in the state, observing a striking reduction in lethality correlated to the vaccinated fraction of the population; although lower lethality rates were not much affected by the Omicron variant wave, the same effect was not translated in the number of infections. In summary, our results provide a general overview of the pandemic’s course in Paraná State and how there was reduction in lethality after a combination of multiple infection waves and a large-scale vaccination program.

1 April 2022 in Ciencia & Saude Coletiva
Verified
Journal Article
Open access
CPCarla Rocha Pereira
Carla Rocha Pereira
MCMarly Marques da Cruz
Marly Marques da Cruz
VCVanda Lúcia Cota
Vanda Lúcia Cota
BABernardo Montesanti Machado de Almeida
Bernardo Montesanti Machado de Almeida
Resumo Este estudo tem por objetivo analisar a vinculação ao tratamento de HIV/Aids de Homens que fazem Sexo com Homens (HSH) no Projeto A Hora é Agora, na cidade de Curitiba, Paraná. O conceito de vulnerabilidade com seus três eixos: individual, social e programático foi considerado o marco teórico. Realizou-se levantamento das barreiras enfrentadas pelos sujeitos da testagem até o início do tratamento, por meio de registro da linkagem e atas das reuniões de supervisão. Os dados revelaram que, no plano individual, os HSH tiveram dificuldade em aceitar o diagnóstico de HIV, além de problemas psicológicos que podem ter acarretado na demora de início do tratamento. No eixo social, o estigma/discriminação foi identificado no atendimento nas Unidades Básicas de Saúde e na família, protelando a revelação da sorologia. Por fim, no eixo programático, os HSH encontraram entraves no acesso aos serviços de saúde em função: dos pedidos para repetirem o teste de HIV; mudança de médico pelo mau atendimento; e obstáculos na realização de outros exames, refletindo negativamente no cuidado da saúde. Para a superação dessas barreiras recomenda-se uma atuação não apenas macroestrutural frente a esse grupo, mas um investimento na micropolítica, possibilitando uma mudança real de atitude, cuidado contínuo e postura frente a abordagem do cuidador e a defesa da vida.

6 April 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
BRBruna Winkert Raddatz
Bruna Winkert Raddatz
FRFelipe Jansen Rabello
Felipe Jansen Rabello
RBRafael Benedetti
Rafael Benedetti
GSGisleine J Steil
Gisleine J Steil
LILouise Matiê Imamura
Louise Matiê Imamura
MFMarcus Vinícius Mazega Figueredo
Marcus Vinícius Mazega Figueredo
Quick and reliable mass testing of infected people is an effective tool for the contingency of SARS-CoV-2. During the COVID-19 pandemic, Point-of-Care (POC) tests using Loop-Mediated Isothermal Amplification (LAMP) arose as a useful diagnostic tool. LAMP tests are a robust and fast alternative to Polymerase Chain Reaction (PCR), and their isothermal property allows easy incorporation into POC platforms. The main drawback of using colorimetric LAMP is the reported short-term stability of the pre-mixed reagents, as well as the relatively high rate of false-positive results. Also, low-magnitude amplification can produce a subtle color change, making it difficult to discern a positive reaction. This paper presents Hilab Molecular, a portable device that uses the Internet of Things and Artificial Intelligence to pre-analyze colorimetric data. In addition, we established manufacturing procedures to increase the stability of colorimetric RT-LAMP tests. We show that ready-to-use reactions can be stored for up to 120 days at −20 °C. Furthermore, we validated both the Hilab Molecular device and the Hilab RT-LAMP test for SARS-CoV-2 using 581 patient samples without any purification steps. We achieved a sensitivity of 92.93% and specificity of 99.42% (samples with CT ≤ 30) when compared to RT-qPCR.

11 May 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
AGAléxia Thamara Gasparin
Aléxia Thamara Gasparin
CAClaudiane Isabel Franco Araujo
Claudiane Isabel Franco Araujo
MCMônica Ribas Cardoso
Mônica Ribas Cardoso
PSPatricia Schmitt
Patricia Schmitt
Juliana Beker GodoyJuliana Beker Godoy
Juliana Beker Godoy
MFMarcus Vinícius Mazega Figueredo
Marcus Vinícius Mazega Figueredo
The complete blood count (CBC) is a highly requested test that is generally restricted to centralized laboratories, which are limited by high cost, being maintenance-demanding, and requiring costly equipment. The Hilab System (HS) is a small, handheld hematological platform that uses microscopy and chromatography techniques, combined with machine learning (ML) and artificial intelligence (AI), to perform a CBC test. This platform uses ML and AI techniques to add higher accuracy and reliability to the results besides allowing for faster reporting. For clinical and flagging capability evaluation of the handheld device, the study analyzed 550 blood samples of patients from a reference institution for oncological diseases. The clinical analysis encompassed the data comparison between the Hilab System and a conventional hematological analyzer (Sysmex XE-2100) for all CBC analytes. The flagging capability study compared the microscopic findings from the Hilab System and the standard blood smear evaluation method. The study also assessed the sample collection source (venous or capillary) influences. The Pearson correlation, Student t-test, Bland–Altman, and Passing–Bablok plot of analytes were calculated and are shown. Data from both methodologies were similar (p > 0.05; r ≥ 0.9 for most parameters) for all CBC analytes and flagging parameters. Venous and capillary samples did not differ statistically (p > 0.05). The study indicates that the Hilab System provides humanized blood collection associated with fast and accurate data, essential features for patient wellbeing and quick physician decision making.

1 February 2021 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
MFMatheus Gomes Ferreira
Matheus Gomes Ferreira
VSValeria Cristina Scavasine
Valeria Cristina Scavasine
GBGiovanni Luís Breda
Giovanni Luís Breda
BABernardo Montesanti Machado de Almeida
Bernardo Montesanti Machado de Almeida
VZViviane de Hiroki Flumignan Zétola
Viviane de Hiroki Flumignan Zétola
MLMarcos Christiano Lange
Marcos Christiano Lange
Background: Syphilis is an endemic disease, particularly in low- and middle-income countries, with vascular involvement in large vessels (aortitis), but no clear relationship with stroke patients, except for those who presented with meningovascular neurosyphilis. Objective: To investigate the relationship between a positive history of syphilis determined by serological testing and ischemic stroke etiology, particularly small vessel disease (SVD). Methods: In total, 269 first-ever ischemic stroke patients admitted to the stroke unit were tested for syphilis. Patients with neurosyphilis were excluded. All patients were classified according to the ASCOD phenotyping as SVD — when SVD was the potential causal mechanism (S1) — or non-SVD — when SVD was uncertain (S2), unlike (S3), or not detected (S0). Results: Syphilis was positive in 32 (12%) patients. When comparing patients with positive and negative serology, the only significant difference was SVD as the causal mechanism (S1) in patients with positive results: 9 (28%) vs. 22 (9%), p<0.01. Conclusion: The current study showed that the frequency of positive syphilis serological test was higher in patients with first-ever ischemic stroke and SVD as the potential causal mechanism. This finding could be related to the endothelial dysfunction occurring in syphilis.

10 June 2024 in Sensors
Verified
Journal Article
Open access
PDF file
Ava GevaerdAva Gevaerd
Ava Gevaerd
ECEmmanuelle Carneiro
Emmanuelle Carneiro
JGJeferson L. Gogola
Jeferson L. Gogola
Diego Rinaldi Pavesi NicolleteDiego Rinaldi Pavesi Nicollete
Diego Rinaldi Pavesi Nicollete
ESErika Bergamo Santiago
Erika Bergamo Santiago
MFMarcus Vinícius Mazega Figueredo
Marcus Vinícius Mazega Figueredo
This paper reports a rapid and sensitive sensor for the detection and quantification of the COVID-19 N-protein (N-PROT) via an electrochemical mechanism. Single-frequency electrochemical impedance spectroscopy was used as a transduction method for real-time measurement of the N-PROT in an immunosensor system based on gold-conjugate-modified carbon screen-printed electrodes (Cov-Ag-SPE). The system presents high selectivity attained through an optimal stimulation signal composed of a 0.0 V DC potential and 10 mV RMS−1 AC signal at 100 Hz over 300 s. The Cov-Ag-SPE showed a log response toward N-PROT detection at concentrations from 1.0 ng mL−1 to 10.0 μg mL−1, with a 0.977 correlation coefficient for the phase (θ) variation. An ML-based approach could be created using some aspects observed from the positive and negative samples; hence, it was possible to classify 252 samples, reaching 83.0, 96.2 and 91.3% sensitivity, specificity, and accuracy, respectively, with confidence intervals (CI) ranging from 73.0 to 100.0%. Because impedance spectroscopy measurements can be performed with low-cost portable instruments, the immunosensor proposed here can be applied in point-of-care diagnostics for mass testing, even in places with limited resources, as an alternative to the common diagnostics methods.